Alpha Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.95M Sell
49,486
-785
-2% -$90.6K 0.86% 36
2025
Q4
$5.29M Buy
50,271
+882
+2% +$82.8K 0.75% 46
2025
Q3
$4.15M Buy
49,389
+2,551
+5% +$210K 0.66% 56
2025
Q2
$3.71M Buy
46,838
+4,072
+10% +$324K 0.64% 56
2025
Q1
$3.84M Buy
42,766
+3,394
+9% +$317K 0.73% 53
2024
Q4
$3.92M Buy
39,372
+2,040
+5% +$210K 0.72% 50
2024
Q3
$4.24M Buy
37,332
+672
+2% +$79.8K 0.8% 44
2024
Q2
$4.54M Buy
36,660
+249
+0.7% +$32.1K 0.88% 38
2024
Q1
$4.8M Sell
36,411
-339
-0.9% -$41.8K 0.94% 35
2023
Q4
$4.01M Buy
36,750
+718
+2% +$74.5K 0.83% 46
2023
Q3
$3.71M Sell
36,032
-580
-2% -$62.5K 0.87% 44
2023
Q2
$4.06M Hold
36,612
1.02% 36
2023
Q1
$4.06M Hold
36,612
1.02% 36
2022
Q4
$4.06M Sell
36,612
-6,892
-16% -$704K 1.02% 36
2022
Q3
$3.75M Buy
43,504
+1,048
+2% +$93.6K 0.99% 34
2022
Q2
$3.87M Buy
42,456
+1,778
+4% +$158K 1.06% 30
2022
Q1
$3.34M Buy
40,678
+3,031
+8% +$239K 0.73% 49
2021
Q4
$2.88M Buy
37,647
+1,319
+4% +$105K 0.64% 55
2021
Q3
$2.73M Buy
36,328
+2,581
+8% +$196K 0.65% 57
2021
Q2
$2.63M Sell
33,747
-584
-2% -$43.4K 0.62% 55
2021
Q1
$2.52M Buy
34,331
+2,087
+6% +$154K 0.64% 49
2020
Q4
$2.52M Buy
32,244
+315
+1% +$24.1K 0.64% 52
2020
Q3
$2.53M Sell
31,929
-1,003
-3% -$78.6K 0.73% 43
2020
Q2
$2.43M Buy
32,932
+604
+2% +$45.5K 0.83% 43
2020
Q1
$2.37M Buy
32,328
+614
+2% +$48.3K 1.05% 29
2019
Q4
$2.75M Sell
31,714
-2,978
-9% -$245K 1.01% 36
2019
Q3
$2.79M Buy
34,692
+1,300
+4% +$104K 1.03% 34
2019
Q2
$2.67M Buy
33,392
+295
+0.9% +$22.6K 1.01% 34
2019
Q1
$2.63M Sell
33,097
-7,467
-18% -$558K 1.03% 30
2018
Q4
$2.96M Sell
40,564
-1,995
-5% -$141K 1.38% 13
2018
Q3
$2.88M Sell
42,559
-369
-0.9% -$23.5K 1.16% 21
2018
Q2
$2.49M Buy
42,928
+2,912
+7% +$164K 1.01% 27
2018
Q1
$2.08M Buy
40,016
+1,565
+4% +$84.5K 0.89% 39
2017
Q4
$2.06M Sell
38,451
-1,729
-4% -$95.9K 0.97% 37
2017
Q3
$2.46M Buy
40,180
+837
+2% +$50.7K 1.17% 24
2017
Q2
$2.41M Buy
39,343
+479
+1% +$29.2K 1.19% 23
2017
Q1
$2.36M Buy
38,864
+1,777
+5% +$108K 1.64% 17
2016
Q4
$2.08M Sell
37,087
-5,898
-14% -$345K 1.43% 30
2016
Q3
$2.56M Sell
42,985
-142
-0.3% -$8.3K 1.86% 18
2016
Q2
$2.37M Sell
43,127
-2,224
-5% -$118K 1.71% 24
2016
Q1
$2.29M Buy
+45,351
New +$2.22M 1.66% 27

Other funds holding MRK

Alpha Capital Management's MRK Position: Q1 2026 in Review

Alpha Capital Management reduced its Merck (MRK) stake by 1.6% in Q1 2026, selling an estimated $90.6K and leaving 49,486 shares worth $5.95M. The position accounts for 0.86% of the portfolio, ranked #36.

Alpha Capital Management first reported a position in MRK in Q1 2016 and has held it in 41 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Alpha Capital Management held 49,486 shares of Merck worth $5.95M as of Q1 2026.
  • Alpha Capital Management sold 785 Merck shares in Q1 2026, an estimated $90.6K.
  • Merck made up 0.86% of Alpha Capital Management's portfolio in Q1 2026, its #36 holding.
  • Alpha Capital Management first reported a position in Merck in Q1 2016 and has held it in 41 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Alpha Capital Management's 13F filing for Q1 2026, filed 13 May 2026.